LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 50 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,921,000 | +332.7% | 257,857 | +302.9% | 0.00% | – |
Q4 2016 | $444,000 | -24.9% | 64,006 | -10.8% | 0.00% | – |
Q3 2016 | $591,000 | -80.9% | 71,750 | -81.2% | 0.00% | -100.0% |
Q2 2016 | $3,093,000 | +31.3% | 381,851 | -17.7% | 0.00% | 0.0% |
Q1 2016 | $2,356,000 | +1277.8% | 463,764 | +1994.3% | 0.00% | – |
Q4 2015 | $171,000 | +55.5% | 22,144 | +16.1% | 0.00% | – |
Q3 2015 | $110,000 | -74.1% | 19,076 | -45.7% | 0.00% | – |
Q1 2015 | $425,000 | – | 35,131 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayer Capital Management, LP | 2,823,333 | $25,890,000 | 96.51% |
Avoro Capital Advisors LLC | 2,923,065 | $26,805,000 | 7.38% |
ACUTA CAPITAL PARTNERS, LLC | 886,000 | $8,125,000 | 5.02% |
Perceptive Advisors | 2,759,593 | $25,305,000 | 1.52% |
Ghost Tree Capital, LLC | 350,000 | $3,210,000 | 1.04% |
Broadfin Capital, LLC | 1,812,419 | $16,620,000 | 0.89% |
P.A.W. CAPITAL CORP | 80,000 | $734,000 | 0.74% |
Rhenman & Partners Asset Management AB | 556,000 | $5,099,000 | 0.61% |
Cormorant Asset Management, LP | 499,815 | $4,583,000 | 0.61% |
Trellus Management Company, LLC | 38,500 | $353,000 | 0.40% |